Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Gilead Sciences (GILD) Q1 2020 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction. The company did not provide guidance for fiscal 2020, due to the coronavirus-driven uncertainty.

Gilead Sciences Q1 2020 earnings infographic

First-quarter adjusted earnings increased to $1.68 per share from $1.67 per share a year earlier. Analysts were looking for a smaller bottom-line number.

Net income, on an unadjusted basis, came in at $1.55 billion or $1.22 per share, compared to $1.98 billion or $1.54 per share in the prior-year period. The improvement primarily reflects favorable tax effects and gains from equity securities.

Revenues moved up 5% year-over-year to $5.55 billion and exceeded the market’s prediction. The company’s stock closed Thursday’s regular trading higher, hut slipped into the negative territory during the after-hours session.

Most Popular

HD Stock: What’s in store for Home Depot after record second quarter

Home improvement is one of the top activities that kept Americans busy during the pandemic, a trend that enabled The Home Depot, Inc. (NYSE: HD) to beat the crisis and

Target (TGT) stock drops after Q2 earnings miss estimates; revenue up 4%

Department store chain Target Corporation (NYSE: TGT) reported a sharp decline in adjusted earnings for the second quarter of 2022, despite an increase in net sales. The bottom line also fell

Amazon (AMZN) stock remains a good bet despite poor results. Here’s why

Amazon.com, Inc. (NASDAQ: AMZN) became an inspiration for other players in the eCommerce sector as the online retailer successfully channelized its resources to tap into the spike in demand for

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top